Please use this identifier to cite or link to this item: https://hdl.handle.net/10955/328
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGabriele,Sabrina-
dc.contributor.authorAndò,Sebastiano-
dc.contributor.authorBonofiglio,Daniela-
dc.date.accessioned2013-10-24T11:38:35Z-
dc.date.available2013-10-24T11:38:35Z-
dc.date.issued2013-10-24-
dc.identifier.urihttp://hdl.handle.net/10955/328-
dc.descriptionDottorato di Ricerca in Biochimica Cellulare ed Attività dei Farmaci in Oncologia, XX Ciclo, SSDen_US
dc.description.sponsorshipUniversità della Calabriaen_US
dc.language.isoenen_US
dc.relation.ispartofseriesMED/04;-
dc.subjectPatologia cellulareen_US
dc.subjectCarcinomaen_US
dc.subjectCarcinomaen_US
dc.titlePPARgamma ligand rosiglitazone inhibits cell growth proliferation and induces apoptosis in breast cancer cellsen_US
dc.typeThesisen_US
Appears in Collections:Dipartimento di Farmacia e Scienze della Salute e della Nutrizione - Tesi di Dottorato

Files in This Item:
File Description SizeFormat 
Tesi.pdf1,59 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.